Abstract:The role and method of image-based staging of anal cancer has evolved with the rapid development of newer imaging modalities and the need to address the rising incidence of this rare cancer. In 2014, the European Society of Medical Oncology mandated pelvic magnetic resonance imaging (MRI) for anal cancer and subsequently other societies such as the National Comprehensive Cancer Network followed suit with similar recommendations. Nevertheless, great variability exists from center to center and even within individual centers. Notably, this is in stark contrast to the imaging of the anatomically nearby rectal cancer. As participating team members for this malignancy, we embarked on a comprehensive literature review of anal cancer imaging to understand the relative merits of these new technologies which developed after computed tomography (CT), e.g., MRI and positron emission tomography/computed tomography (PET/CT). The results of this literature review helped to inform our next stage: questionnaire development regarding the imaging of anal cancer. Next, we distributed the questionnaire to members of the Society of Abdominal Radiology (SAR) Rectal and Anal Disease-Focused Panel, a group of abdominal radiologists with special interest, experience, and expertise in rectal and anal cancer, to provide expert radiologist opinion on the appropriate anal cancer imaging strategy. In our expert opinion survey, experts advocated the use of MRI in general (65% overall and 91-100% for primary staging clinical scenarios) and acknowledged the superiority of PET/CT for nodal assessment (52-56% agreement for using PET/CT in primary staging clinical scenarios compared to 30% for using MRI). We therefore support the use of MRI and PET and suggest further exploration of PET/MRI as an optimal combined evaluation. Our questionnaire responses emphasized the heterogeneity in imaging practice as performed at numerous academic cancer centers across the United States and underscore the need for further reconciliation and establishment of best imaging practice guidelines for optimized patient care in anal cancer.

MRI for Rectal Cancer: Updates and Controversies- AJR Expert Panel Narrative Review

MRI of Rectal Cancer: An Overview and Update on Recent Advances

The importance of MRI for rectal cancer evaluation

Anatomic Basis of Rectal Cancer Staging: Clarifying Controversies and Misconceptions

Advances in MRI-Based Assessment of Rectal Cancer Post-Neoadjuvant Therapy: A Comprehensive Review

Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting

Modern MR Imaging Technology in Rectal Cancer; There Is More Than Meets the Eye

MRI anatomy of the rectum: key concepts important for rectal cancer staging and treatment planning

Progress of MRI in predicting the circumferential resection margin of rectal cancer: A narrative review

Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology

MRI restaging of rectal cancer: The RAC (Response-Anal canal-CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups

The optimized rectal cancer MRI protocol: choosing the right sequences, sequence parameters, and preparatory strategies

Rectal Cancer Magnetic Resonance Imaging: Imaging Beyond Morphology

Current imaging of rectal cancer

Restaging magnetic resonance imaging of the rectum after neoadjuvant therapy: a practical guide

Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician

The use of PET/MRI for imaging rectal cancer

MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer

The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer

MRI for Restaging Locally Advanced Rectal Cancer: Detailed Analysis of Discrepancies with the Pathologic Reference Standard

MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report